Journal
ENVIRONMENTAL EPIGENETICS
Volume 5, Issue 3, Pages -Publisher
OXFORD UNIV PRESS
DOI: 10.1093/eep/dvz012
Keywords
prostate mesenchymal cells; bisphenol A; ethinylestradiol; DOHaD; hormone action; plastic; estrogen receptor; fetal exposure; DNA methylation; epigenetics
Categories
Funding
- global DNA methylation ELISA
- National Institute of Environmental Health Sciences [ES020952, U54KD104310, ES0001332]
Ask authors/readers for more resources
Fetal/neonatal environmental estrogen exposures alter developmental programing of the prostate gland causing onset of diseases later in life. We have previously shown in vitro that exposures to 17 beta-estradiol (E2) and the endocrine disrupting chemical bisphenol A, at concentrations relevant to human exposure, cause an elevation of estrogen receptor alpha (Esr1) mRNA in primary cultures of fetalmouse prostatemesenchymal cells; a similar result was observed in the fetal rat urogenital sinus. Effects of these chemicals on prostatemesenchyme in vivo are not well understood. Here we show effects inmice of fetal exposure to the estrogenic drug inmixed oral contraceptives, 17 alpha-ethinylestradiol (EE2), at a concentration of EE2 encountered by human embryos/fetuses whosemothers become pregnant while on EE2-containing oral contraceptives, or bisphenol A at a concentration relevant to exposures observed in human fetuses in vivo. Expression of Esr1 was elevated by bisphenol A or EE2 exposures, which decreased the global expression of DNA methyltransferase 3A (Dnmt3a), whilemethylation of Esr1 promoter was significantly increased. These results show that exposures to the environmental estrogen bisphenol A and drug EE2 cause transcriptional and epigenetic alterations to expression of estrogen receptors in developing prostate mesenchyme in vivo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available